loading
전일 마감가:
$3.16
열려 있는:
$3.2
하루 거래량:
307.64K
Relative Volume:
0.53
시가총액:
$182.06M
수익:
$163.78M
순이익/손실:
$25.88M
주가수익비율:
5.0615
EPS:
0.65
순현금흐름:
$-28.66M
1주 성능:
+0.61%
1개월 성능:
+11.90%
6개월 성능:
-40.51%
1년 성능:
-62.87%
1일 변동 폭
Value
$3.16
$3.37
1주일 범위
Value
$3.15
$3.37
52주 변동 폭
Value
$2.645
$9.55

Voyager Therapeutics Inc Stock (VYGR) Company Profile

Name
명칭
Voyager Therapeutics Inc
Name
전화
857-259-5340
Name
주소
75 HAYDEN AVENUE, LEXINGTON, MA
Name
직원
172
Name
트위터
@VoyagerTx
Name
다음 수익 날짜
2025-03-11
Name
최신 SEC 제출 서류
Name
VYGR's Discussions on Twitter

VYGR을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
VYGR
Voyager Therapeutics Inc
3.29 170.16M 163.78M 25.88M -28.66M 0.65
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
477.86 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
575.47 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
327.45 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
572.00 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.33 29.19B 3.81B -644.79M -669.77M -6.24

Voyager Therapeutics Inc Stock (VYGR) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-01-10 개시 Cantor Fitzgerald Overweight
2024-12-02 개시 Citigroup Buy
2024-11-29 재개 Wedbush Outperform
2024-10-16 개시 Leerink Partners Outperform
2024-03-26 개시 Guggenheim Buy
2024-03-19 개시 H.C. Wainwright Buy
2024-03-07 개시 Citigroup Buy
2024-01-02 업그레이드 Wells Fargo Equal Weight → Overweight
2023-05-10 개시 Truist Buy
2023-03-10 개시 Oppenheimer Outperform
2021-10-07 업그레이드 Robert W. Baird Neutral → Outperform
2021-02-26 다운그레이드 Robert W. Baird Outperform → Neutral
2021-02-03 다운그레이드 BTIG Research Buy → Neutral
2021-02-03 다운그레이드 Wedbush Outperform → Neutral
2020-12-24 다운그레이드 Cantor Fitzgerald Overweight → Neutral
2020-12-23 다운그레이드 Raymond James Outperform → Mkt Perform
2020-11-11 다운그레이드 Oppenheimer Outperform → Perform
2020-11-10 다운그레이드 Raymond James Strong Buy → Outperform
2020-11-10 다운그레이드 Wells Fargo Overweight → Equal Weight
2020-03-19 개시 The Benchmark Company Buy
2020-02-06 개시 Oppenheimer Outperform
2018-11-15 업그레이드 Raymond James Outperform → Strong Buy
2018-09-10 재개 BTIG Research Buy
2018-09-10 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2018-06-04 개시 H.C. Wainwright Buy
2018-03-12 다운그레이드 Evercore ISI Outperform → In-line
2018-03-12 다운그레이드 Wedbush Outperform → Neutral
2018-02-02 개시 Morgan Stanley Overweight
2017-11-28 재개 Piper Jaffray Overweight
2017-10-31 개시 Robert W. Baird Outperform
2017-10-27 개시 Canaccord Genuity Buy
2017-10-23 재확인 Stifel Buy
2017-10-12 개시 Raymond James Outperform
2017-08-17 개시 Evercore ISI Outperform
2017-07-28 재개 Stifel Buy
모두보기

Voyager Therapeutics Inc 주식(VYGR)의 최신 뉴스

pulisher
04:30 AM

Is Voyager Therapeutics Inc. a good long term investmentHigh-yield trading alerts - Autocar Professional

04:30 AM
pulisher
01:42 AM

Voyager Therapeutics Inc. Stock Analysis and ForecastExplosive market performance - jammulinksnews.com

01:42 AM
pulisher
Jul 22, 2025

What drives Voyager Therapeutics Inc. stock priceTriple-digit returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Why Voyager Therapeutics Inc. stock attracts strong analyst attentionFree Smart Money Stock Analysis - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Voyager Therapeutics’ Promising Alzheimer’s Study: A Potential Game-Changer? - MSN

Jul 22, 2025
pulisher
Jul 20, 2025

Why did Voyager's net profit surge in Q4 2024 despite high operating expenses? - AInvest

Jul 20, 2025
pulisher
Jul 20, 2025

What analysts say about Voyager Therapeutics Inc. stockMarket-crushing stock picks - Autocar Professional

Jul 20, 2025
pulisher
Jul 19, 2025

Does Voyager Therapeutics Inc. stock pay reliable dividendsTrend Based Entry Alerts - beatles.ru

Jul 19, 2025
pulisher
Jul 17, 2025

Voyager Therapeutics adds new gene therapy to Alzheimer’s program - BioWorld MedTech

Jul 17, 2025
pulisher
Jul 17, 2025

Baird reiterates Outperform rating on Voyager Therapeutics stock with $18 price target - Investing.com Canada

Jul 17, 2025
pulisher
Jul 17, 2025

Voyager Adds Fourth Wholly-Owned Alzheimer’s Disease - GlobeNewswire

Jul 17, 2025
pulisher
Jul 16, 2025

How Voyager Therapeutics Inc. stock performs during market volatilityDaily Top Gainers - Newser

Jul 16, 2025
pulisher
Jul 16, 2025

Voyager Therapeutics Introduces New Program Targeting Genetic Risk Factor of Alzheimer's Disease - 富途牛牛

Jul 16, 2025
pulisher
Jul 16, 2025

Voyager Therapeutics Launches New Gene Therapy Program Targeting APOE for Alzheimer's Disease Treatment - Quiver Quantitative

Jul 16, 2025
pulisher
Jul 16, 2025

Voyager Therapeutics unveils APOE-targeting Alzheimer’s therapy program By Investing.com - Investing.com South Africa

Jul 16, 2025
pulisher
Jul 16, 2025

Voyager Therapeutics unveils APOE-targeting Alzheimer’s therapy program - Investing.com

Jul 16, 2025
pulisher
Jul 16, 2025

Voyager Adds Fourth Wholly-Owned Alzheimer’s Disease Program to Pipeline, Complementing Existing Tau and Amyloid Assets with New APOE Approach - GlobeNewswire Inc.

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Voyager Therapeutics Inc. stock price move sharplyBreakout Setup Scanner - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

Allspring Global Investments Holdings LLC Buys 21,149 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World

Jul 12, 2025
pulisher
Jul 05, 2025

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Average Rating of “Buy” from Brokerages - Defense World

Jul 05, 2025
pulisher
Jun 25, 2025

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Shares Sold by Rhumbline Advisers - Defense World

Jun 25, 2025
pulisher
Jun 18, 2025

Financial Comparison: Prime Medicine (NYSE:PRME) & Voyager Therapeutics (NASDAQ:VYGR) - Defense World

Jun 18, 2025
pulisher
Jun 17, 2025

Voyager Therapeutics at H.C. Wainwright: Genetic Innovation in Focus By Investing.com - Investing.com Canada

Jun 17, 2025
pulisher
Jun 11, 2025

Equities Analysts Offer Predictions for VYGR FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Jun 10, 2025
pulisher
Jun 10, 2025

Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspecti - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference | VYGR Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference - GlobeNewswire

Jun 10, 2025
pulisher
Jun 09, 2025

Millennium Management LLC Sells 60,935 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World

Jun 09, 2025
pulisher
Jun 08, 2025

Squarepoint Ops LLC Decreases Position in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

Voyager Therapeutics: Navigating AAV Headwinds And A Long Road For VY7523 (Downgrade) - Seeking Alpha

Jun 06, 2025
pulisher
Jun 05, 2025

Voyager Therapeutics Approves Stock Plans at Annual Meeting - TipRanks

Jun 05, 2025
pulisher
Jun 05, 2025

BNP Paribas Financial Markets Sells 43,210 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Holdings Lowered by ProShare Advisors LLC - Defense World

Jun 04, 2025
pulisher
Jun 02, 2025

Deutsche Bank AG Cuts Stock Position in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World

Jun 02, 2025
pulisher
Jun 02, 2025

Pre-market Movers: LYRA, INM, OGEN, VERA... - RTTNews

Jun 02, 2025
pulisher
Jun 01, 2025

Oppenheimer Predicts Up to ~550% Jump for These 2 ‘Strong Buy’ Stocks - Yahoo Finance

Jun 01, 2025

Voyager Therapeutics Inc (VYGR) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Voyager Therapeutics Inc 주식 (VYGR) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Sandrock Alfred
President and CEO
Apr 02 '25
Sale
3.43
10,885
37,336
430,931
$22.88
price up icon 4.89%
$36.03
price down icon 0.17%
$102.40
price down icon 0.38%
$27.79
price up icon 4.56%
$113.71
price up icon 2.09%
biotechnology ONC
$295.12
price down icon 0.09%
자본화:     |  볼륨(24시간):